Johnson & Johnson

EU regulator backs J&J COVID-19 booster dose in adults

Dec 15 (Reuters) - The European Union's drug regulator on Wednesday recommended that a booster dose of Johnson & Johnson's COVID-19 vaccine may be given at least two months after…

Read More Here

Healthcare giant Johnson & Johnson to split into two companies

Nov 12 (Reuters) - Healthcare conglomerate Johnson & Johnson said on Friday it is planning to break up into two companies, splitting off its consumer health division that sells Band-Aids…

Read More Here

EU finds J&J COVID shot possibly linked to another rare clotting condition

Oct 1 (Reuters) - The European Union's drug regulator said on Friday there is a possible link between rare cases of bloods clots in deep veins with Johnson & Johnson's…

Read More Here

UPDATED: EU reviewing cases of rare body inflammation after COVID-19 shots

Europe's medicines regulator said on Friday it was reviewing if there was a risk of a rare inflammatory condition after inoculation with COVID-19 vaccines, following a report of one case…

Read More Here

South African study shows J&J vaccine protects against death

Johnson & Johnson COVID-19 vaccine is working well in South Africa, offering protection against severe disease and death, the head of a trial in the country said on Friday. The…

Read More Here

EU lists rare nerve disorder as side-effect of J&J COVID-19 vaccine

Europe's medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson's COVID-19 vaccine after it reviewed…

Read More Here

J&J raises revenue forecast, estimates $2.5 bln in COVID-19 vaccine sales

Johnson & Johnson raised its 2021 revenue estimates on Wednesday and forecast it would sell $2.5 billion worth of its COVID-19 vaccine this year, as it strives to quell production…

Read More Here

UPDATED: J&J’s COVID-19 vaccine shows promise against Delta variant

Johnson & Johnson said late Thursday that its single-shot COVID-19 vaccine showed promise against the highly contagious Delta variant in a laboratory study. An analysis of blood from eight patients…

Read More Here

Denmark continues exclusion of J&J, AstraZeneca COVID-19 vaccines

Danish health authorities said on Friday that COVID-19 vaccines from AstraZeneca and Johnson & Johnson would remain excluded from Denmark's vaccine roll-out following a review of new safety data. "The…

Read More Here

EU foregoes 100 million J&J vaccines, considers donating other doses

The European Union decided not to take up an option to buy 100 million doses of the Johnson & Johnson's COVID-19 vaccine and is considering donating another 100 million optional…

Read More Here

UPDATED: Belgium says halts J&J COVID jab for under 41s after one dies

The Belgian government said on Wednesday it was suspending vaccinations with Johnson & Johnson's Janssen COVID-19 vaccine for people under the age of 41 following the death of a woman…

Read More Here

Ireland considering giving AstraZeneca, J&J vaccines to ages 40-49

Irish health officials are considering allowing the use of COVID-19 vaccines from AstraZeneca and Johnson & Johnson for those aged between 40 and 49 in addition to the current use…

Read More Here

Germany to lift prioritisation for J&J COVID-19 vaccine

Germany is to make Johnson & Johnson's COVID-19 vaccine available to all adults, Health Minister Jens Spahn said on Monday, adding that they will be able to receive the shot…

Read More Here

UPDATED: Norway should exclude J&J, AstraZeneca from COVID vaccination scheme, says commission

Norway should exclude the COVID-19 vaccines made by AstraZeneca and Johnson & Johnson from its inoculation programme due to a risk of rare but harmful side-effects, a government-appointed commission said…

Read More Here

UPDATED: Poland ready to buy J&J shots from Denmark

Poland has offered to buy Johnson & Johnson COVID-19 vaccines from Denmark, a government spokesman said on Wednesday, after Copenhagen excluded the shots from its vaccination programme over a potential…

Read More Here

U.S. ends J&J COVID-19 vaccine pause; shots to resume immediately

The United States can immediately resume use of Johnson & Johnson's COVID-19 vaccine, top health regulators said on Friday, ending a 10-day pause to investigate its link to extremely rare…

Read More Here

Germany sets no limits on use of J&J COVID-19 shot

Germany has decided not to impose limits on the use of Johnson & Johnson's COVID-19 vaccine, the head of the country's vaccine regulator said on Friday, adding the expert panel…

Read More Here

UPDATED: U.S. CDC probes new death, hospitalization after J&J vaccine shots

The U.S. Centers for Disease Control and Prevention (CDC) is investigating the death of an Oregon woman and the hospitalization of another in Texas after receiving Johnson & Johnson's COVID-19…

Read More Here

UK scientists find higher risk of brain clots from COVID-19 compared with vaccines

There is a much higher risk of brain blood clots from COVID-19 infection than there is from vaccines against the disease, British researchers said on Thursday, after the rollout of…

Read More Here

UPDATED: EU Commission to end AstraZeneca and J&J vaccine contracts at expiry

The EU Commission has decided not to renew COVID-19 vaccine contracts next year with AstraZeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on Wednesday, citing a source…

Read More Here

Johnson & Johnson begins COVID-19 vaccine supplies to EU

Johnson & Johnson on Monday began delivering its COVID-19 single-dose vaccine to EU countries, European Union officials and the company said. The company had initially planned to start its deliveries…

Read More Here

EU reviews J&J COVID-19 vaccine for blood clots, expands AstraZeneca probe

April 9 (Reuters) - Europe's drug regulator said on Friday it had started reviewing reports of a bleeding condition in people who had received AstraZeneca's COVID-19 vaccine and was also…

Read More Here

J&J set to begin India trial of its single-shot vaccine

Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot COVID-19 vaccine in the country, the Indian Express newspaper reported on Friday. The…

Read More Here

Tunisia approves Johnson & Johnson COVID-19 vaccine

Tunisia approved Johnson & Johnson’s COVID-19 vaccine, the health minister Faouzi Mehdi said, and will soon receive 1.5 million doses of the vaccine under an African Union plan. The North…

Read More Here

J&J says batch of COVID-19 vaccine ingredient fails to meet quality standards

Johnson & Johnson announced it had found a problem with a batch of drug substance for its COVID-19 vaccine, which did not meet quality standards at Emergent Biosolutions’ production site…

Read More Here

J&J to make up to three billion COVID-19 vaccines in 2022

Johnson & Johnson’s chief scientist said the company expects to produce up to 3 billion doses of its COVID-19 vaccine next year, after the European Union approved the one-shot immunization.…

Read More Here

U.S. near authorization of Johnson & Johnson COVID-19 vaccine

U.S. regulators said they would work quickly to authorize Johnson & Johnson’s COVID-19 vaccine for emergency use after a panel of outside advisers backed the one-shot immunization. The Food and…

Read More Here

Johnson & Johnson single shot vaccine ‘safe and effective’

The United States expects to roll out three to four million doses of Johnson & Johnson's COVID-19 vaccine next week, pending authorization from the Food and Drug Administration, White House…

Read More Here

Four EU states urge EU to safeguard Johnson & Johnson vaccine supply

ATHENS, Feb 5 (Reuters) - The leaders of Denmark, Austria, the Czech Republic and Greece have urged the European Commission to act quickly to secure supplies of the COVID-19 vaccine…

Read More Here

Major new coronavirus vaccine trial starts in UK

Johnson & Johnson launched a new late-stage trial in Britain on Monday to test a two-dose regimen of its experimental COVID-19 vaccine among thousands of volunteers, as the U.S. drugmaker…

Read More Here

EU signs supply deal with J&J on potential COVID-19 vaccine

The European Commission said on Wednesday it had signed a contract on behalf of EU states with U.S. drugmaker Johnson & Johnson for the supply of 400 million doses of…

Read More Here

UPDATED: EU seals supply deal with Johnson & Johnson on COVID-19 vaccine

The European Commission said on Thursday it had sealed a supply deal with Johnson & Johnson for the supply of its potential COVID-19 vaccine for up to 400 million people.…

Read More Here

Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial

A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim results published…

Read More Here

Johnson & Johnson’s Janssen to start mid-stage coronavirus vaccine trials in 3 European countries next week

Johnson & Johnson's Janssen unit will begin mid-stage trials for its coronavirus vaccine in Spain, the Netherlands and Germany next week, Spain's health minister said on Friday, as the U.S.…

Read More Here

Johnson & Johnson fined US$ 572 million in relation to US opioid crisis

An Oklahoma judge on Monday found Johnson & Johnson and its subsidiaries helped fuel the state's opioid crisis and ordered the consumer products giant to pay $572 million to clean…

Read More Here

Johnson & Johnson ordered to pay $4.69 billion in talc cancer lawsuit

CNN/AFP: US pharmaceutical giant Johnson & Johnson was Thursday ordered to pay out $4.69 billion in damages in a lawsuit representing 22 women and their families who alleged a talc sold…

Read More Here